Specific Contract For The Supply Of The Drug Solitoris 300Mg (Active Ingredient Eculizumab), Through The Use Of The Sintel Sda Platform

Name: Specific Contract For The Supply Of The Drug Solitoris 300Mg (Active Ingredient Eculizumab), Through The Use Of The Sintel Sda Platform
Start: 2025-08-28
End: 2025-09-03
Location: Fondazione IRCCS Istituto Neurologico Besta

Fondazione IRCCS Istituto Neurologico Besta Italy has Released a tender for Specific Contract For The Supply Of The Drug Solitoris 300Mg (Active Ingredient Eculizumab), Through The Use Of The Sintel Sda Platform in Healthcare and Medicine. The tender was released on Aug 27, 2025.

Country - Italy

Summary - Specific Contract For The Supply Of The Drug Solitoris 300Mg (Active Ingredient Eculizumab), Through The Use Of The Sintel Sda Platform

Deadline - Sep 03, 2025

GT reference number - 116581513

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

Address - Italy

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 116581513

Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Specific Contract For The Supply Of The Drug Solitoris 300Mg (Active Ingredient Eculizumab), Through The Use Of The Sintel Sda Platformlocal title:: Appalto specifico per la fornitura del farmaco SOLIRIS 300mg (principio attivo ECULIZUM AB), mediante l’utilizzo della piattaforma Sintel SDAContract Type: : SupplyNet Budget Euro: : 1042688.0Net Budget LC: : 1042688.0Tender URL: : https://www.ariaspa.it/wps/portal/Aria/Home/bandi-convenzioni/e-procurement/strumenti-di-supporto/guide-e-manuali est_amount: 1042688.0

Gt Ref Id - 116581513

Deadline - Sep 03, 2025